Cytologic evaluation of exclusive medroxyprogesterone acetate treatment for vaginal recurrence of endometrial adenocarcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000284:Administration, Oral; D004967:Estrogens / Q000032:analysis; D005260:Female; D006651:Histocytochemistry; D006801:Humans; D007273:Injections, Intramuscular; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013997:Time Factors; D014594:Uterine Neoplasms / Q000188:drug therapy*; D014621:Vagina / Q000032:analysis / Q000473:pathology*; D014625:Vaginal Neoplasms / Q000188:drug therapy*; D014626:Vaginal Smears
D004967:Estrogens; D008525:Medroxyprogesterone